Trademark Overview
On Wednesday, July 3, 2024, a trademark application was filed for RETAKU with the United States Patent and Trademark Office. The USPTO has given the RETAKU trademark a serial number of 98631462. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Saturday, December 28, 2024. This trademark is owned by Acucela Inc.. The RETAKU trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceuticals; ophthalmic preparations; pharmaceuticals and therapeutic agents for treatment of ophthalmic diseases, namely, therapeutic pharmaceutical for the treatment of ophthalmic diseases, biological pharmaceutical preparations for the treatment of ophthalmic diseases, and gene therapy pharmaceutical preparations for the treatment of ophthalmic diseases